Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age

Summary

This study is an observational study (Non-interventional study) to evaluate the safety and efficacy of favipiravir in patients older than 15 years of age, diagnosed with COVID-19 and initiated treatment with favipiravir before enrollment to the study. Patients who have already had a routine favipiravir treatment decision or alternatively favipiravir treatment started at the time of enrollment, will be included in this study.

Conditions

• COVID-19

Interventions

DRUG

Favipiravir

Turkish patient cohort diagnosed with COVID-19 and previously initiated treatment with "Favipiravir".

Sponsors & Collaborators

• Hacettepe University

  collaborator OTHER

• Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

  collaborator OTHER

• Umraniye Education and Research Hospital

  collaborator OTHER_GOV

• Istanbul Training and Research Hospital

  collaborator OTHER_GOV

• Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

  collaborator OTHER

• Tepecik Training and Research Hospital

  collaborator OTHER

• Istanbul University - Cerrahpasa

  collaborator OTHER

• Ankara University

  collaborator OTHER

• Ankara City Hospital Bilkent

  collaborator OTHER

• Ankara Training and Research Hospital

  collaborator OTHER

• Ege University Hospital (Application and Research Center)

  collaborator UNKNOWN

• Derince Training and Research Hospital

  collaborator OTHER

• Istanbul University

  collaborator OTHER

• Kayseri City Hospital

  collaborator OTHER_GOV

• Ministry of Health, Turkey

  lead OTHER_GOV

Eligibility

Min Age

15 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-06-11

Primary Completion

2020-12-31

Completion

2021-06-01

Countries

• Turkey (Türkiye)

Study Locations